Get started
Author

V. N. Nesterova

Observed names: V.N. Nesterova, Valentina N Nesterova, Valentina N. Nesterova
ORCID: 0000-0002-2456-7971
Observed ORCID: 0000-0002-2456-7971
OpenAlex ID: A5068880870
Non-immunogenic recombinant staphylokinase versus alteplase for patients with acute ischaemic stroke 4·5 h after symptom onset in Russia (FRIDA): a randomised, open label, multicentre, parallel-group, non-inferiority trial
2021 · Eugene I Gusev, Mikhail Yu Martynov, et al. · The Lancet Neurology · 103
Nonimmunogenic staphylokinase in the treatment of acute ischemic stroke (FRIDA trial results)
2022 · E.I. Gusev, M.Yu. Martynov, et al. · S S Korsakov Journal of Neurology and Psychiatry · 32
Prognostic Value of Investigating Neuron-Specific Enolase in Patients with Ischemic Stroke
2021 · A.S. Kurakina, T.N. Semenova, et al. · Современные технологии в медицине · 25
PDF
Thrombolysis With the Non-Immunogenic Staphylokinase for Acute Ischemic Stroke in the FORPI Registry: An Observational Study
2025 · Nikolay A. Shamalov, Mikhail Yu Martynov, et al. · Stroke · 12
Fortelyzin for acute ischaemic stroke treatment: an open, prospective, non-interventional, observational study FORPI registry
2025 · N.A. Shamalov, M.Yu. Martynov, et al. · S S Korsakov Journal of Neurology and Psychiatry · 5
Fortelyzin for acute ischaemic stroke treatment in an extended (4.5 to 24 hours from the onset of symptoms) time window: data from the observational study FORPI registry
2026 · N.A. Shamalov, M.Yu. Martynov, et al. · S S Korsakov Journal of Neurology and Psychiatry · 4
Transient Global Amnesia in the Practice of a Neurologist in Emergency Room of Stroke Center
2015 · V. N. Grigoryeva, V. N. Nesterova, et al. · The Neurological Journal · 4
Fortelizin in bridging therapy of acute ischemic stroke: data from the observational study FORPI registry
2026 · N.A. Shamalov, M.Yu. Martynov, et al. · S S Korsakov Journal of Neurology and Psychiatry · 3
Fortelyzin in the treatment of acute ischemic stroke in patients ≥80 years old: data from the observational study FORPI registry
2026 · N.A. Shamalov, M.Yu. Martynov, et al. · S S Korsakov Journal of Neurology and Psychiatry · 2
Thrombolytic therapy with Revelisa in ischemic stroke: results of the PRIMA international multicenter observational study
2025 · N. A. Shamalov, D. R. Khasanova, et al. · Neurology neuropsychiatry Psychosomatics · 2
PDF
Thrombolytic Therapy for Ischemic Stroke with Revelise: Results of a Two-Year Follow-Up in the International PRIMA Study
2025 · N.A. Shamalov, D.R. Khasanova, et al. · S S Korsakov Journal of Neurology and Psychiatry · 1
Fortelyzin in the treatment of minor acute ischemic stroke according to a subanalysis of the observational study FORPI registry
2026 · N. A. Shamalov, M. Yu. Martynov, et al. · Neurology neuropsychiatry Psychosomatics
PDF
Fortelyzin in the treatment of acute ischemic stroke due to basilar-artery occlusion: data from the observational study FORPI registry
2026 · N. A. Shamalov, M. Yu. Martynov, et al. · Neurology neuropsychiatry Psychosomatics
PDF
Neurocutaneous melanocytosis with manifestation in adulthood
2022 · V. N. Grigoryeva, V. N. Nesterova, et al. · Russian neurological Journal
Analysis of stroke case fatality in regional stroke center during the COVID-19 pandemic
2021 · V. N. Grigoryeva, E. V. Guzanova, et al. · Russian neurological Journal
Прогностическое Значение Исследования Нейронспецифической Енолазы У Пациентов С Ишемическим Инсультом
2021 · А С Куракина, Т Н Семенова, et al. · Современные технологии в медицине
Синдром Гийена-Барре с бульбарными нарушениями, атаксией и гиперсомнией в дебюте заболевания
2018 · В Н Григорьева, V. N. Nesterova · CyberLeninK (CyberLeninka)
Works count: 17
Citation count: 193
H-index: 5
I10-index: 4
Year
Topic
Type